Antitumor Activity of Oxali-Titanocene Y in Xenografted CAKI-1 Tumors in Mice

E-ISSN： 1875-628x|5|8|489-493

ISSN： 1570-1808

Source： Letters in Drug Design & Discovery, Vol.5, Iss.8, 2008-12, pp. : 489-493

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antitumor Activity of Titanocene Y in Xenografted PC3 Tumors in Mice

Letters in Drug Design & Discovery, Vol. 5, Iss. 2, 2008-03 ,pp. : 141-144

Bentham Science Publishers

Access to resources Recommend Favorite

The Activity of Titanocene T Against Xenografted Caki-1 Tumors

Letters in Drug Design & Discovery, Vol. 10, Iss. 5, 2013-06 ,pp. : 375-381

Bentham Science Publishers

Access to resources Recommend Favorite

The Cytotoxicity of Titanocene Y Against CAKI-1 Cells: An In Vitro Formulation Study

Letters in Drug Design & Discovery, Vol. 7, Iss. 5, 2010-01 ,pp. : 310-317

Bentham Science Publishers

Access to resources Recommend Favorite

The Antiangiogenic and Antitumoral Activity of Titanocene Y* In Vivo

Letters in Drug Design & Discovery, Vol. 8, Iss. 4, 2011-05 ,pp. : 302-307

Bentham Science Publishers

Access to resources Recommend Favorite

Ultrasound enhanced antitumor activity of liposomal doxorubicin in mice

By Hagtvet Eirik Evjen Tove J. Olsen Dag Rune Fossheim Sigrid L. Nilssen Esben A.

Journal of Drug Targeting, Vol. 19, Iss. 8, 2011-09 ,pp. : 701-708

Informa Healthcare

Access to resources Recommend Favorite